News

20 September 2016

Strengthening gene therapy for Huntington’s disease

A single injection of a new treatment has reduced the activity of the gene responsible for Huntington’s disease for several months in a trial in mice.

20 September 2016

"Dedos de Zinc, una posible solución a la enfermedad de Huntington" (CRG / Diario Médico)

"Dedos de Zinc, una posible solución a la enfermedad de Huntington" (CRG / Diario Médico)
20 September 2016

"Una inyección reduce la enfermedad de Huntington en ratones durante varios meses" (CRG / La Vanguardia.com)

"Una inyección reduce la enfermedad de Huntington en ratones durante varios meses" (CRG / La Vanguardia.com)
15 September 2016

The long-sought cure to Huntington's disease (CRG / Cordis)

The long-sought cure to Huntington's disease (CRG / Cordis)
15 September 2016

"The long-sought cure to Huntington's disease" (CRG / Cordis)

"The long-sought cure to Huntington's disease" (CRG / Cordis)
8 September 2016

The long-sought cure to Huntington's disease (CRG / Research EU Results Magazine)

The long-sought cure to Huntington's disease (CRG / Research EU Results Magazine)
8 September 2016

"The long-sought cure to Huntington's disease" (CRG / Research EU Results Magazine)

"The long-sought cure to Huntington's disease" (CRG / Research EU Results Magazine)
1 July 2016

CRG Proof of Concept: Commercialization Gap Fund (CGF)

Deadline (Short Submission): 01/09/2016

Please send your application (max. 2 pages) under the following schemes:

  • MIDI - Up to 6 months and 35 kEUR
  • MAXI - Up to 12 months and 75 kEUR

Read More

 

1 July 2016

3rd CRG BioBusiness School (Extended Deadline)

12th-16th September 2016

Based on the great success of the former editions, the 3rd CRG Bio-Business School shall:

  • Raise awareness about technology transfer among the participants through lectures and hands-on practical sessions;
  • Teach the challenges, opportunities and tools to successfully transfer basic knowledge "from the lab to the marketplace";
  • Identify projects with technology transfer/business potential that could otherwise remain undisclosed;
  • Match basic science in biomedicine, bioinformatics, etc. with business;
  • Have participants function as "signal amplifiers", able to spread the knowledge acquired amongst other colleagues, and apply it to new projects;
  • Stimulate a culture of innovation and entrepreneurship.

Registration is free and open online. Click here to register. Deadline (extended) 08 July2016

Read More